Clinical trial
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial…
NCT00104949 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00104949 |
|---|---|
| Title | Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma |
| Official title | Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological |
| Interventions | trastuzumab |
| Enrollment | 40 |
| Start date | Jul 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Mar 4, 2005 |
| Last update posted | Jun 24, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: